The Week — Pharmaceutical company CEO says he has a ‘moral requirement’ to sell drugs at the highest price

Summary:
Because "shareholder value." [Nirmal Mulye, chief executive of Nostrum Laboratories,] told FT he agreed with Martin "Pharma Bro" Shkreli raising the price of AIDS and cancer drug Daraprim in 2015 from .50 to 0 per tablet, saying he was "within his rights because he had to reward his shareholders." We live in a "capitalist economy and if you can't make money you can't stay in business," Mulye said. "We have to make money when we can. Appropriately, nirman means "no mind."The Week Pharmaceutical company CEO says he has a 'moral requirement' to sell drugs at the highest price Catherine Garcia

Topics:
Mike Norman considers the following as important: capitalism, shareholder value

This could be interesting, too:

Stavros Mavroudeas writes Is Neoliberalism still the dominant economic paradigm in the West today? – S.Mavroudeas

Peter Radford writes Here we are

Peter Radford writes The Geology of Economics?

Dean Baker writes Capitalism and Democracy: The market is far more flexible than Christopher Caldwell imagines